Literature DB >> 21611914

[The "wheel gymnast's elbow" - first description of a common overuse syndrome].

M D Kauther1, S Rummel, B Thobe, B Hussmann, D Nast-Kolb, C Wedemeyer.   

Abstract

BACKGROUND: Overuse syndromes of the elbow due to wheel gymnastics are unknown in medical literature. This study describes a common overuse syndrome of the elbow in wheel gymnastics.
METHODS: We conducted internet research and interviewed 260 wheel gymnasts, who trained the "hip roll" element.
RESULTS: 60.4 % of the gymnasts reported changes of the elbow region. The intensity of pain during training was 1.51 out of 10 points. Lacerations were reported in 33.1 %, hematomas were reported in 68.7 %, and a loss of hair at the elbow region was reported in 11.7 %. 11.5 % of the gymnasts described a bump and 5.8 % described a depression of the proximal ulnar region that was not found before wheel gymnastics. Gymnasts using protective gear reported significantly higher levels of pain compared to gymnasts without protective gear. DISCUSSION: The "wheel gymnast's elbow" is a common overuse syndrome of the proximal ulnar due to direct contact and friction of the proximal ulnar to the giant wheel bars. The "wheel gymnast's elbow" describes a combination of lacerations, hematoma, hair loss, bumps, and depression of the proximal ulnar region with only slight pain.
CONCLUSION: An early preventive use of protective gear during "hip roll" training can possibly reduce the "wheel gymnast's elbow" syndrome. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2011        PMID: 21611914     DOI: 10.1055/s-0029-1245841

Source DB:  PubMed          Journal:  Sportverletz Sportschaden        ISSN: 0932-0555            Impact factor:   1.077


  1 in total

1.  Wheel-gymnastic-related injuries and overuse syndromes of amateurs and professionals.

Authors:  Max Daniel Kauther; Silvia Rummel; Bjoern Hussmann; Sven Lendemans; Christian Wedemeyer; Marcus Jaeger
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-02-21       Impact factor: 4.342

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.